 HIV protease inhibitors are peptide-like chemicals that competitively inhibit the action of the virus aspartyl protease.These drugs prevent proteolytic cleavage of HIV Gag and Pol polyproteins that include essential structural and enzymatic components of the virus.This prevents the conversion of HIV particles into their mature infectious form.